Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.01 USD | +1.01% | -8.15% | -13.45% |
Apr. 09 | Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday | MT |
Apr. 09 | Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study | MT |
Financials (USD)
Sales 2024 * | 1.53B | Sales 2025 * | 1.54B | Capitalization | 4.02B |
---|---|---|---|---|---|
Net income 2024 * | 351M | Net income 2025 * | 342M | EV / Sales 2024 * | 2.12 x |
Net cash position 2024 * | 791M | Net cash position 2025 * | 1.17B | EV / Sales 2025 * | 1.85 x |
P/E ratio 2024 * |
11.7
x | P/E ratio 2025 * |
12.4
x | Employees | 2,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.39% |
Latest transcript on Alkermes plc
1 day | +1.62% | ||
1 week | -7.59% | ||
Current month | -10.77% | ||
1 month | -12.26% | ||
3 months | -12.77% | ||
6 months | -12.67% | ||
Current year | -12.92% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Pops
CEO | Chief Executive Officer | 62 | 91-01-31 |
Blair Jackson
DFI | Director of Finance/CFO | 51 | 98-12-31 |
Shane Cooke
PSD | President | 61 | 11-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Pops
CEO | Chief Executive Officer | 62 | 91-01-31 |
Nancy Snyderman
BRD | Director/Board Member | 72 | 16-05-25 |
Brian McKeon
BRD | Director/Board Member | 61 | 20-12-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
15.32% | 215 M€ | +11.98% | - | |
2.65% | 1 M€ | -1.52% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 24.01 | +1.01% | 2 257 016 |
24-04-16 | 23.77 | -1.04% | 1,579,931 |
24-04-15 | 24.02 | -1.64% | 2,713,260 |
24-04-12 | 24.42 | -2.28% | 1,895,023 |
24-04-11 | 24.99 | -4.40% | 2,076,481 |
Delayed Quote Nasdaq, April 17, 2024 at 03:48 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.92% | 4.02B | |
-1.50% | 41.71B | |
+47.70% | 41.56B | |
+3.98% | 39.74B | |
-15.14% | 25.61B | |
+3.60% | 24.26B | |
-23.73% | 18.55B | |
-2.28% | 11.93B | |
+24.93% | 11.93B | |
+7.40% | 10.91B |
- Stock Market
- Equities
- ALKS Stock